Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Orexigen Therapeutics Inc. (developing obesity treatments) has netted $87.3mm through the public sale of 5.6mm units at $15.94. Each unit consists of one common share and a ten-year warrant to buy ten shares of common stock at $1.45 apiece.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?